ALCHEMIST <span style="font-weight:normal"><i>(The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)</i></span>: Questions and Answers
ALCHEMIST represents three integrated, precision medicine trials that are designed to identify people with early-stage lung cancer who have tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those mol
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1085893.htm
- Syndication ID: 19363
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:13 PM
- Date Syndication Updated: Thursday, November 12, 2020 at 07:07 AM
Tags
General:
treatment
trial
drug
screening
lung
tumor
genetic
childhood acute lymphoblastic leukemia
T-cell childhood acute lymphoblastic leukemia
Philadelphia chromosome-positive childhood acute lymphoblastic leukemia
gene
marker
mutation
ALK
EGFR
survival
ALCHEMIST
Embed Code Snippet
To get the embed code snippet please Login.
